|
|
|
1
|
Host factors that may increase likelihood of asthma include: genetics, sex, pre-term size for gestational age, and
|
|
6
|
This medication (brand) is used as a once-daily maintenance treatment as an alternative adjunct to ICS + LABA in patients with a history of exacerbations.
|
|
8
|
What is the generic name of Spiriva?
|
|
10
|
What is the brand name of fluticasone-salmeterol?
|
|
11
|
Environmental factors that may increase likelihood of asthma include: occupational sensitizers and allergens, infections, microbiome, exposure to tobacco smoke, air pollution, diet, stress, and
|
|
12
|
This medication is reserved for use in severe asthma due to high risk for overdose, narrow therapeutic index, and drug-drug interactions.
|
|
15
|
One way to control environmental factors is by avoiding non-selective beta-blockers. What is an example of a non-selective beta-blocker?
|
|
18
|
The MOA of this medication (generic) blocks the effects of leukotrienes and is commonly given to children due to availability of chewable tablets.
|
|
19
|
When comparing the Anti-IL-5 and Anti-IL-5R, which one is indicated as an add-on maintenance treatment for patients with severe asthma aged 18 years and older with an eosinophilic phenotype and is only available as IV infusion?
|
|
20
|
According to GINA, asthma is defined as “a heterogeneous disease, usually characterized by chronic airway…”
|
|
21
|
What medication (generic) may be given to a patient with acute asthma symptoms and/or exacerbations?
|
|
22
|
Common side effects of this short acting medication (generic) include: dry mouth, abnormal taste, and blurred vision.
|
|
25
|
This medication (brand) is the only combination drug (ICS/LABA) that is dosed as 1 inhalation once daily.
|
|
29
|
This class of medications may also be used in the management of acute asthma symptoms however, it is not FDA approved for asthma and children under 12.
|
|
30
|
This Anti-IL-5 medication (brand) has no monitoring requirements for IgE levels and is given as 100 mg subcutaneously every 4 weeks regardless of the patient’s weight.
|
|
|
|
|
|
|
2
|
Common side effects of albuterol include: hypokalemia, nausea, tremors, headaches, pharyngitis, feeling nervous and...
|
|
3
|
Omalizumab (Xolair) dosing and frequency is determined by two factors: body weight (kg) and baseline serum...
|
|
4
|
Controlling ___ conditions (such as GERD, obesity, rhinitis/sinusitis, OSA, etc.) is an important key factor when managing chronic asthma.
|
|
5
|
Which medication (brand) has a black box warning for anaphylaxis which may occur at any time from the 1st dose to more than a year after initiation of treatment?
|
|
7
|
This class of medications is the most effective first line therapy for all levels of persistent asthma. It is important to counsel patients on rinsing their mouths after usage of this class of medications
|
|
9
|
What is the mechanism of action of Cromolyn?
|
|
13
|
This class of medications has black boxed warnings when used alone to treat asthma. It must be used in combination with an ICS for the treatment of asthma.
|
|
14
|
What is the brand name of beclomethasone?
|
|
16
|
This class of medications is used as an alternative therapy in step 2 of the guidelines, and is most commonly associated with neuropsychiatric events.
|
|
17
|
Signs and symptoms consistent with diagnosis of asthma include: history of cough, difficulty breathing, chest tightness, and
|
|
23
|
A patient is taking Asmanex 440 mcg daily. What strength ICS is this considered?
|
|
24
|
An objective measure to establish diagnosis, monitoring of asthma and assess the presence, severity, and reversibility of airflow obstruction
|
|
26
|
The four components of asthma care include: assessment and monitoring, medications, control environmental factors and co-morbid conditions and
|
|
27
|
A patient is taking Pulmicort 180 mcg daily. What strength ICS is this considered?
|
|
28
|
Daily management such as environmental control and how to recognize and manage inadequate asthma control such as signs and symptoms are all part of the asthma...
|
|
|
|
